Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Aino Launonen being referenced
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aino Launonen | 145 | 168 | 48 | 70 | 23 | 291 | |
| Esther Ravinsky | 80 | 68 | 19 | 13 | 23 | 292 | |
| Giorgia Annechini | 143 | 129 | 71 | 64 | 24 | 280 | |
| Heather Symecko | 33 | 109 | 6 | 24 | 24 | 288 | |
| Sushmita Gordhandas | 76 | 88 | 5 | 34 | 33 | 312 | |
| Natalia Castrejón de Anta | 77 | 107 | 33 | 8 | 17 | 192 | |
| Per Frisk | 43 | 44 | 37 | 53 | 27 | 215 | |
| Maktav Dinçer | 50 | 105 | 6 | 21 | 22 | 308 | |
| U Lecca | 52 | 30 | 32 | 12 | 18 | 285 | |
| Johannes Rosenbrock | 119 | 123 | 9 | 109 | 23 | 273 | |
| Nicoletta Provinciali | 37 | 171 | 6 | 21 | 22 | 298 |
All Works
Loading papers...